MAOB and glioma: In conclusion, this study demonstrates that our novel MAO-B inhibitors are able to contrast glioma proliferation by arresting the cell cycle and drastically increasing oxidative stress conditions, as well as the invasiveness by markedly reducing the migration of malignant cells.